Skip to main content
. 2017 Feb 15;5(1):4. doi: 10.3390/diseases5010004

Table 3.

Antibiogram of urinary bacterial isolates from SCD patients and healthy controls.

ISOLATES SOURCE BA CL CH PR TE CP AK AS SC OF NX LE
E. coli SCD S S R S S S S R S S S S
E. coli SCD S S R R R S S R S S S S
E. coli SCD R S S S R S S R S S S S
E. coli SCD S R S R R R S R S S S S
E. coli NSCD S S S S R S S R S S S S
E. coli NSCD R R R R R S S R S R S R
CNS NSCD R S S S S S S S S S S S
CNS NSCD R R R S S S S R S S S S
CNS NSCD R I R S S S S R S S S S
CNS NSCD S R R S R S S R S S S S
CNS NSCD R S S S R S S R S S S S
CNS SCD R R S S R R S S I S S S
CNS SCD S S S S S S S S S S S S
CNS SCD S R S R R S I R S S S S
CNS SCD S S R S S S S R S S S S
K. oxytoca SCD R S R R R S S R S S S S
S. aureus NSCD S S S S S S S R S S S S
S. aureus SCD S S S S S S S R S S S S
Enterobacter sp. SCD S S R S S S S S S S S S
Enterobacter sp. SCD S S R R R S S R S S S S
Enterobacter sp. SCD R S R S S S S R S S S S
Citrobacter sp. SCD R R S R R S R R S S S S

S. aureusStaphylococcus aureus; K. oxytocaKlebsiella oxytoca; CNS—coagulase-negative Staphylococcus sp.; E. coliEscherichia coli; SCD—sickle cell disease; NSCD—non-sickle cell disease; R—resistant; S—susceptible; I—intermediate; BA—cotrimoxazole; AK—amikacin; CL—ceftizoxime; AS—ampicillin; CH—chloramphenicol; SC—sparfloxacin; PR—cephalexin; OF—ofloxacin; TE—tetracycline; NX—norfloxacin; CP—ciprofloxacin; LE—levofloxacin.